332 related articles for article (PubMed ID: 32867726)
21. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
Gao J; Song L; Li D; Peng L; Ding H
Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.
Xu CH; Zhan P; Yu LK; Zhang XW
Tumour Biol; 2014 Feb; 35(2):1599-603. PubMed ID: 24072496
[TBL] [Abstract][Full Text] [Related]
23. The value of apolipoprotein E in distinguishing benign and malignant unilateral pleural effusions.
Xue Q; Fang G; Deng X; Zhang C; Liu Z; Peng Z; Lai Z; Peng Y; Wu J
Medicine (Baltimore); 2020 Mar; 99(10):e19320. PubMed ID: 32150067
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
25. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
27. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
[TBL] [Abstract][Full Text] [Related]
28. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of the cancer ratio for the prediction of malignant pleural effusion: evidence from a validation study and meta-analysis.
Zhang Y; Li X; Liu J; Hu X; Wan C; Zhang R; Shen Y
Ann Med; 2021 Dec; 53(1):558-566. PubMed ID: 33818231
[TBL] [Abstract][Full Text] [Related]
31. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
Tian T; Li J; Hu W; Sun C; Zhou J
J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
[TBL] [Abstract][Full Text] [Related]
32. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
Biaoxue R; Min L; Tian F; Wenlong G; Hua L
BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
[TBL] [Abstract][Full Text] [Related]
33. Pleural and serum markers for diagnosis of malignant pleural effusion.
Allama AM; Abou-Elela DH; Ibrahim IM
Asian Cardiovasc Thorac Ann; 2020 Nov; 28(9):560-565. PubMed ID: 32741198
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Values of sVEGFR-1 and Endostatin in Malignant Pleural Effusions in Patients with Lung Cancer.
Zhu YY; Wu HM; Liu RY
Clin Lab; 2017 Sep; 63(9):1371-1378. PubMed ID: 28879702
[TBL] [Abstract][Full Text] [Related]
35. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial.
Botana-Rial M; Vázquez-Iglesias L; Casado-Rey P; Cadena MP; Andrade-Olivié MA; Abal-Arca J; García-Nimo L; Ferreiro-Fernández L; Valdés-Cuadrado L; San-José ME; Rodríguez-Berrocal FJ; Fernández-Villar A
Sci Rep; 2020 Mar; 10(1):5679. PubMed ID: 32231227
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
[TBL] [Abstract][Full Text] [Related]
37. Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study.
Cao XS; Yan L; Jiang TW; Huang JH; Chen H; Porcel JM; Zheng WQ; Hu ZD
Ther Adv Respir Dis; 2024; 18():17534666231222333. PubMed ID: 38189269
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
[No Abstract] [Full Text] [Related]
39. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis.
Tian P; Shen Y; Wan C; Yang T; An J; Yi Q; Chen L; Wang T; Wang Y; Wen F
Int J Clin Exp Pathol; 2014; 7(9):5880-7. PubMed ID: 25337230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
